Imbruvica

List of products in the National Drug Code with proprietary name imbruvica. This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system).

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
57962-007Imbruvica IbrutinibSuspensionOralPharmacyclics LlcHuman Prescription Drug
57962-014Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcHuman Prescription Drug
57962-070Imbruvica IbrutinibCapsuleOralPharmacyclics LlcHuman Prescription Drug
57962-140Imbruvica IbrutinibCapsuleOralPharmacyclics LlcHuman Prescription Drug
57962-280Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcHuman Prescription Drug
57962-420Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcHuman Prescription Drug
57962-560Imbruvica IbrutinibTablet, Film CoatedOralPharmacyclics LlcHuman Prescription Drug